Chimeric Antigen Receptor (CAR) T-Cell Products for Pediatric Cancers: Why Alternative Development Paths Are Needed Here, we report the efficacy and safety of P + T in the overall MyPathway HER2 ...
Chimeric Antigen Receptor (CAR) T-Cell Products for Pediatric Cancers: Why Alternative Development Paths Are Needed Authors retain all rights in any data supplements associated with their articles.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results